具有pH/Hyal反应的满载vancomycin的chitooligosaccharide纳米颗粒用于细胞内MRSA感染治疗
Wenting Li1, WeiWei Li1, Xuanxiang Zhai1
1School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, 346 Guanhai Road, Yantai, 264003, PR China.
Materials today. Bio
|April 25, 2025
概括
覆盖着氨酸的奇多利高糖化物纳米颗粒有效地向并杀死细胞内黄金葡萄球菌,包括耐美西林菌株,为治疗持久性细菌感染提供了一个有前途的新策略.
科学领域:
- 纳米医学是一种纳米医学.
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 黄金葡萄球菌 (S. aureus) 是一个关键的全球性病原体,细胞内感染由于抗生素透率有限而带来了重大治疗挑战.
- 在巨细胞内有效地根除细胞内金杆菌对于成功治疗至关重要.
- 目前的抗生素往往难以达到细胞内病原体,需要先进的输送系统.
研究的目的:
- 为了设计一种积极向的抗生素载体,以增强菌素的细胞内输送.
- 开发氨酸涂层的奇托氧糖纳米颗粒 (HA/COS@Van) 用于针对性地传递给巨细胞.
- 评估HA/COS@Van对细胞内黄金葡萄球菌感染的疗效.
主要方法:
- 用氨酸 (HA/COS@Van) 涂覆的充满氨酸的奇托奥利高糖纳米颗粒的制造.
- 在实验室中评估S. aureus感染的巨细胞中纳米颗粒吸收的情况,使用共聚焦激光扫描显微镜和流细胞计.
- 在小鼠感染模型 (腹膜炎和器官感染) 中纳米粒子生物分布和治疗疗效的体内评估.
主要成果:
- 在实验室中,HA/COS纳米颗粒在S. aureus感染的巨细胞中表现出有效的积累.
- 静脉注射HA/COS导致肝脏的积累增加,肝脏是感染巨细胞的关键部位,体内.
- 在实验室中,HA/COS@Van表现出相对于自由菌素,更优异的细胞内甲素耐药黄金色杆菌 (MRSA) 的杀死.
- 在急性腹膜炎和器官感染的小鼠模型中,HA/COS@Van显示出增强的杀菌活性.
结论:
- 氨酸涂层增强了纳米粒子的生物相容性,并通过CD44受体相互作用实现了对巨细胞的积极向.
- 在HA/COS@Van系统证明有效的体外和体内向细胞内S. aureus.
- 这种主动准纳米粒子输送系统对改善针对细胞内细菌病原体的治疗结果具有重大前景.
更多相关视频
07:32Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
1.7K
06:42Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
Published on: September 27, 2024
1.3K
相关概念视频
iChip
The cultivation of environmental microorganisms has long been hindered by the inability to replicate complex native conditions in vitro. The isolation chip (iChip) addresses this limitation by facilitating the growth of previously uncultivable microorganisms through in situ incubation. Designed for high-throughput microbial cultivation, the iChip comprises hundreds of microchambers, each capable of housing a single microbial cell. These microchambers are loaded with a mixture of molten agar and...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
